Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

12.63 -0.01 (-0.11%)
Streaming Delayed Price Updated: 10:22 AM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novavax Inc

< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
Looking Into Novavax's Recent Short Interest
Via Benzinga
Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts
The Novavax layoffs are coming for 12% of the company's global workforce. However, NVAX stock itself could shock the market. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts
If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year. 
Via The Motley Fool
1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell
This biotech isn't at the end of the road just yet, but don't bet on a revival. 
Via The Motley Fool
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
The stock is high risk, but rewards could be great if all works out well for Novavax. 
Via The Motley Fool
Is It Too Late to Buy Novavax Stock?
The biotech could fade into irrelevance soon. 
Via The Motley Fool
Where Will Novavax Be in 5 Years?
Can the beaten-down stock turn things around? 
Via The Motley Fool
What's Going On With Novavax Stock?
Novavax Inc (NASDAQ: NVAX) shares are volatile. 
Via Benzinga
Is Novavax Stock a Buy Now?
The company's shares may look cheap on the surface, but don't be too quick to jump in. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Novavax faces a couple of key issues that could be crucial for the stock price. 
Via The Motley Fool
5 Stocks With Short Interest Over 40%: Possible Short Squeeze Plays
Short selling can be profitable, but sometimes when the stock moves against short sellers and begins to rise, the short sellers jump in to buy shares to cover their positions, creating what is called a... 
Via Talk Markets
Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold
Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value. 
Via InvestorPlace
Time to Buy These 3 Stocks That Just Hit a 52-Week Low?
Sometimes buying stocks at a 52-week low is a chance to buy a good company at great prices but you need to see if the business is busted. 
Via InvestorPlace
What's Going On With Novavax Stock Tuesday?
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday. 
Via Benzinga
Where Will Novavax Be in 3 Years?
Novavax shares have plunged from early pandemic highs. 
Via The Motley Fool
Novavax's Earnings: A Preview
Via Benzinga
3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts
High-water price targets from select analysts imply triple-digit gains in the new year for three former highfliers. 
Via The Motley Fool
7 Magnificent Stocks That Can Double Your Money in 2024
Triple-digit returns could be just a click of the buy button away. 
Via The Motley Fool
Smart Shorts: 7 Meme Stocks to Bet Against in 2024
These seven meme stocks have surged as speculators declare "the coast is clear," but a big reversal for each of them may be forthcoming. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Heavily Shorted Stocks That Still Won’t See a Squeeze
These are the heavily shorted stocks to avoid as they are likely to continue trending lower on the back of very weak fundamentals. 
Via InvestorPlace
3 Meme Stocks That Could Fade Away in 2024
These are the meme stocks to avoid or sell as they have extremely weak fundamentals and are unlikely to recover from a financial perspective. 
Via InvestorPlace
What's Going On With Novavax Hitting A New 52-Week Low?
Novavax Inc (NASDAQ: NVAX) shares are trading lower by 4.4% to $5.08 Wednesday afternoon. 
Via Benzinga
This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Camtek Ltd. 
Via Benzinga
3 Short-Squeeze Stocks That Could Take Off Before Year-End
These three short-squeeze stocks are seeing high short interest. They each could see a year-end short squeeze and notable market moves. 
Via InvestorPlace
Could a Short Squeeze Be Coming for These 3 Heavily Shorted Stocks?
Should investors expect any of these stocks to turn their fortunes around next year? 
Via The Motley Fool
Novavax Prepares Further Cost Cuts To Better Align With Demand-Challenged COVID-19 Vaccine Market
Novavax Inc (NASDAQ: NVAX) reported Q3 revenue of $187 million, compared to $735 million in the same period in 2022, beating the  
Via Benzinga
Exposures COVID-19
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
The stock market’s momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co. 
Via Benzinga
Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?
It won't be easy for this company to win back investors, as the business faces some big challenges. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.